Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[ash111]

I posted this a while ago-and still thinking KTOV might be the next CPXX- only reason i cant think of that might explain why other P3 companies w/same sale prediction or less,on same Final stage before Marketing, trading 500m-1B while ktov trading on 20m+ is the fact that kitov is a Foreign Co. IPO' d just last Nov.(now i see Ceo, also mentioned it as a possible reason). btw, a few biotech funds invested here just recently, Sabby the major one, for te first time ever, kitov has solid US insiders).
The billion dollar drug hit the market in 2017. This is faster even than most of well known bios trading 500m and north. cpxx ran 2600%,this year, to over 1B cap while ktov actually beats her: much better balance sheet, zero debt, higher sales prediction, better SS and both should hit the market in 2017 .KTOV trading on a joke market cap of only $28m right now.

CPXX sales prediction: $750m(US+EU) vs KTOV $1B(US alone, Blockbaster potential per Rodman & Renshaw and per LifeSci Capital,$513 M by year 2022, us alone-not including EU market and rest of the World, recent KTOV slides "We estimate that KIT-302 has the potential to save US healthcare system ~ $650M annually").

Phase 3 completed on both. Marketing approval expected for both- 2017.

Market cap: CPXX: $1.1B vs KTOV $28M.

Cash&Debt: CPXX $23M in Cash, $19M Debt vs KTOV $21M in Cash, Zero Debt.

there is no competition between these companies, completely different drugs & market potential. Comparison made just to show major parameters like sales prediction, market cap, market potential, balance sheet...